Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Journal
American journal of hematology
ISSN: 1096-8652
Titre abrégé: Am J Hematol
Pays: United States
ID NLM: 7610369
Informations de publication
Date de publication:
27 May 2024
27 May 2024
Historique:
revised:
09
04
2024
received:
09
10
2023
accepted:
03
05
2024
medline:
27
5
2024
pubmed:
27
5
2024
entrez:
27
5
2024
Statut:
aheadofprint
Résumé
Improved first progression-free survival following allogeneic hematopoietic cell transplantation relapse with the use of immunotherapy.
Types de publication
Letter
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : P30CA033572
Pays : United States
Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Bazarbachi A, Labopin M, Aljurf M, et al. 20‐year steady increase in survival of adult patients with relapsed Philadelphia‐positive acute lymphoblastic leukemia post allogeneic hematopoietic cell transplantation. Clin Cancer Res. 2022;28(5):1004‐1012. doi:10.1158/1078‐0432.Ccr‐21‐2675
Penack O, Peczynski C, Mohty M, et al. How much has allogeneic stem cell transplant–related mortality improved since the 1980s? A retrospective analysis from the EBMT. Blood Adv. 2020;4(24):6283‐6290. doi:10.1182/bloodadvances.2020003418
Aldoss I, Shah BD, Park JH, et al. Sequencing antigen‐targeting antibodies and cellular therapies in adults with relapsed/refractory B‐cell acute lymphoblastic leukemia. Am J Hematol. 2023;98(4):666‐680. doi:10.1002/ajh.26853
Maiti A, DiNardo CD, Wang SA, et al. Prognostic value of measurable residual disease after venetoclax and decitabine in acute myeloid leukemia. Blood Adv. 2021;5(7):1876‐1883. doi:10.1182/bloodadvances.2020003717
Jabbour E, Short NJ, Ravandi F, et al. Combination of hyper‐CVAD with ponatinib as first‐line therapy for patients with Philadelphia chromosome‐positive acute lymphoblastic leukaemia: long‐term follow‐up of a single‐centre, phase 2 study. Lancet Haematol. 2018;5(12):e618‐e627. doi:10.1016/s2352‐3026(18)30176‐5
Ishida Y, Terasako K, Oshima K, et al. Dasatinib followed by second allogeneic hematopoietic stem cell transplantation for relapse of Philadelphia chromosome‐positive acute lymphoblastic leukemia after the first transplantation. Int J Hematol. 2010;92(3):542‐546. doi:10.1007/s12185‐010‐0678‐6